Global Human Rotavirus Vaccine Market Growth 2025-2031

October 2025 | 78 pages | ID: GB85A3EF996CEN
LP Information

Abstracts

The global Human Rotavirus Vaccine market size is predicted to grow from US$ 202 million in 2025 to US$ 248 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.

Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.

LP Information, Inc. (LPI) ' newest research report, the “Human Rotavirus Vaccine Industry Forecast” looks at past sales and reviews total world Human Rotavirus Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Rotavirus Vaccine sales for 2025 through 2031. With Human Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Rotavirus Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Human Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Rotavirus Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Rotavirus Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Rotarix
• RotaTeq
• Rotavac
• Rotavin-M1
• Lanzhou lamb
• Others

Segmentation by Application:

• Hospitals & Clinics
• Academic And Research
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Bharat Biotech
• Merck
• GlaxoSmithKline

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Rotavirus Vaccine market?
What factors are driving Human Rotavirus Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Rotavirus Vaccine market opportunities vary by end market size?
How does Human Rotavirus Vaccine break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Thin Film Drugs Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Oral Thin Film Drugs by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Oral Thin Film Drugs by Country/Region, 2020, 2024 & 2031
2.2 Oral Thin Film Drugs Segment by Type
  2.2.1 Sublingual Film
  2.2.2 Fully Dissolving Dental/Buccal Film
2.3 Oral Thin Film Drugs Sales by Type
  2.3.1 Global Oral Thin Film Drugs Sales Market Share by Type (2020-2025)
  2.3.2 Global Oral Thin Film Drugs Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Oral Thin Film Drugs Sale Price by Type (2020-2025)
2.4 Oral Thin Film Drugs Segment by Application
  2.4.1 Schizophrenia
  2.4.2 Migraine
  2.4.3 Opioid Dependence
  2.4.4 Nausea & Vomiting
  2.4.5 Others
2.5 Oral Thin Film Drugs Sales by Application
  2.5.1 Global Oral Thin Film Drugs Sale Market Share by Application (2020-2025)
  2.5.2 Global Oral Thin Film Drugs Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Oral Thin Film Drugs Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Oral Thin Film Drugs Breakdown Data by Company
  3.1.1 Global Oral Thin Film Drugs Annual Sales by Company (2020-2025)
  3.1.2 Global Oral Thin Film Drugs Sales Market Share by Company (2020-2025)
3.2 Global Oral Thin Film Drugs Annual Revenue by Company (2020-2025)
  3.2.1 Global Oral Thin Film Drugs Revenue by Company (2020-2025)
  3.2.2 Global Oral Thin Film Drugs Revenue Market Share by Company (2020-2025)
3.3 Global Oral Thin Film Drugs Sale Price by Company
3.4 Key Manufacturers Oral Thin Film Drugs Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Oral Thin Film Drugs Product Location Distribution
  3.4.2 Players Oral Thin Film Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ORAL THIN FILM DRUGS BY GEOGRAPHIC REGION

4.1 World Historic Oral Thin Film Drugs Market Size by Geographic Region (2020-2025)
  4.1.1 Global Oral Thin Film Drugs Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Oral Thin Film Drugs Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Thin Film Drugs Market Size by Country/Region (2020-2025)
  4.2.1 Global Oral Thin Film Drugs Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Oral Thin Film Drugs Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Thin Film Drugs Sales Growth
4.4 APAC Oral Thin Film Drugs Sales Growth
4.5 Europe Oral Thin Film Drugs Sales Growth
4.6 Middle East & Africa Oral Thin Film Drugs Sales Growth

5 AMERICAS

5.1 Americas Oral Thin Film Drugs Sales by Country
  5.1.1 Americas Oral Thin Film Drugs Sales by Country (2020-2025)
  5.1.2 Americas Oral Thin Film Drugs Revenue by Country (2020-2025)
5.2 Americas Oral Thin Film Drugs Sales by Type (2020-2025)
5.3 Americas Oral Thin Film Drugs Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Thin Film Drugs Sales by Region
  6.1.1 APAC Oral Thin Film Drugs Sales by Region (2020-2025)
  6.1.2 APAC Oral Thin Film Drugs Revenue by Region (2020-2025)
6.2 APAC Oral Thin Film Drugs Sales by Type (2020-2025)
6.3 APAC Oral Thin Film Drugs Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Oral Thin Film Drugs by Country
  7.1.1 Europe Oral Thin Film Drugs Sales by Country (2020-2025)
  7.1.2 Europe Oral Thin Film Drugs Revenue by Country (2020-2025)
7.2 Europe Oral Thin Film Drugs Sales by Type (2020-2025)
7.3 Europe Oral Thin Film Drugs Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Thin Film Drugs by Country
  8.1.1 Middle East & Africa Oral Thin Film Drugs Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Oral Thin Film Drugs Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Thin Film Drugs Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Thin Film Drugs Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Thin Film Drugs
10.3 Manufacturing Process Analysis of Oral Thin Film Drugs
10.4 Industry Chain Structure of Oral Thin Film Drugs

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Oral Thin Film Drugs Distributors
11.3 Oral Thin Film Drugs Customer

12 WORLD FORECAST REVIEW FOR ORAL THIN FILM DRUGS BY GEOGRAPHIC REGION

12.1 Global Oral Thin Film Drugs Market Size Forecast by Region
  12.1.1 Global Oral Thin Film Drugs Forecast by Region (2026-2031)
  12.1.2 Global Oral Thin Film Drugs Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Thin Film Drugs Forecast by Type (2026-2031)
12.7 Global Oral Thin Film Drugs Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sumitomo Dainippon Pharma Co., Ltd.
  13.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
  13.1.2 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Product Portfolios and Specifications
  13.1.3 Sumitomo Dainippon Pharma Co., Ltd. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sumitomo Dainippon Pharma Co., Ltd. Main Business Overview
  13.1.5 Sumitomo Dainippon Pharma Co., Ltd. Latest Developments
13.2 Pfizer
  13.2.1 Pfizer Company Information
  13.2.2 Pfizer Oral Thin Film Drugs Product Portfolios and Specifications
  13.2.3 Pfizer Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Pfizer Main Business Overview
  13.2.5 Pfizer Latest Developments
13.3 Novartis AG
  13.3.1 Novartis AG Company Information
  13.3.2 Novartis AG Oral Thin Film Drugs Product Portfolios and Specifications
  13.3.3 Novartis AG Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Novartis AG Main Business Overview
  13.3.5 Novartis AG Latest Developments
13.4 ZIM Laboratories Limited
  13.4.1 ZIM Laboratories Limited Company Information
  13.4.2 ZIM Laboratories Limited Oral Thin Film Drugs Product Portfolios and Specifications
  13.4.3 ZIM Laboratories Limited Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 ZIM Laboratories Limited Main Business Overview
  13.4.5 ZIM Laboratories Limited Latest Developments
13.5 Indivior Plc.
  13.5.1 Indivior Plc. Company Information
  13.5.2 Indivior Plc. Oral Thin Film Drugs Product Portfolios and Specifications
  13.5.3 Indivior Plc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Indivior Plc. Main Business Overview
  13.5.5 Indivior Plc. Latest Developments
13.6 Allergan Plc.
  13.6.1 Allergan Plc. Company Information
  13.6.2 Allergan Plc. Oral Thin Film Drugs Product Portfolios and Specifications
  13.6.3 Allergan Plc. Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Allergan Plc. Main Business Overview
  13.6.5 Allergan Plc. Latest Developments
13.7 IntelGenx Corp
  13.7.1 IntelGenx Corp Company Information
  13.7.2 IntelGenx Corp Oral Thin Film Drugs Product Portfolios and Specifications
  13.7.3 IntelGenx Corp Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 IntelGenx Corp Main Business Overview
  13.7.5 IntelGenx Corp Latest Developments
13.8 NAL Pharma
  13.8.1 NAL Pharma Company Information
  13.8.2 NAL Pharma Oral Thin Film Drugs Product Portfolios and Specifications
  13.8.3 NAL Pharma Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 NAL Pharma Main Business Overview
  13.8.5 NAL Pharma Latest Developments
13.9 Wolters Kluwer
  13.9.1 Wolters Kluwer Company Information
  13.9.2 Wolters Kluwer Oral Thin Film Drugs Product Portfolios and Specifications
  13.9.3 Wolters Kluwer Oral Thin Film Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Wolters Kluwer Main Business Overview
  13.9.5 Wolters Kluwer Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Human Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Rotavirus Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotarix
Table 4. Major Players of RotaTeq
Table 5. Major Players of Rotavac
Table 6. Major Players of Rotavin-M1
Table 7. Major Players of Lanzhou lamb
Table 8. Major Players of Others
Table 9. Global Human Rotavirus Vaccine Sales by Type (2020-2025) & (K Units)
Table 10. Global Human Rotavirus Vaccine Sales Market Share by Type (2020-2025)
Table 11. Global Human Rotavirus Vaccine Revenue by Type (2020-2025) & ($ million)
Table 12. Global Human Rotavirus Vaccine Revenue Market Share by Type (2020-2025)
Table 13. Global Human Rotavirus Vaccine Sale Price by Type (2020-2025) & (USD/Unit)
Table 14. Global Human Rotavirus Vaccine Sale by Application (2020-2025) & (K Units)
Table 15. Global Human Rotavirus Vaccine Sale Market Share by Application (2020-2025)
Table 16. Global Human Rotavirus Vaccine Revenue by Application (2020-2025) & ($ million)
Table 17. Global Human Rotavirus Vaccine Revenue Market Share by Application (2020-2025)
Table 18. Global Human Rotavirus Vaccine Sale Price by Application (2020-2025) & (USD/Unit)
Table 19. Global Human Rotavirus Vaccine Sales by Company (2020-2025) & (K Units)
Table 20. Global Human Rotavirus Vaccine Sales Market Share by Company (2020-2025)
Table 21. Global Human Rotavirus Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Human Rotavirus Vaccine Revenue Market Share by Company (2020-2025)
Table 23. Global Human Rotavirus Vaccine Sale Price by Company (2020-2025) & (USD/Unit)
Table 24. Key Manufacturers Human Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 25. Players Human Rotavirus Vaccine Products Offered
Table 26. Human Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Human Rotavirus Vaccine Sales by Geographic Region (2020-2025) & (K Units)
Table 30. Global Human Rotavirus Vaccine Sales Market Share Geographic Region (2020-2025)
Table 31. Global Human Rotavirus Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Human Rotavirus Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Human Rotavirus Vaccine Sales by Country/Region (2020-2025) & (K Units)
Table 34. Global Human Rotavirus Vaccine Sales Market Share by Country/Region (2020-2025)
Table 35. Global Human Rotavirus Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Human Rotavirus Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 38. Americas Human Rotavirus Vaccine Sales Market Share by Country (2020-2025)
Table 39. Americas Human Rotavirus Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Human Rotavirus Vaccine Sales by Type (2020-2025) & (K Units)
Table 41. Americas Human Rotavirus Vaccine Sales by Application (2020-2025) & (K Units)
Table 42. APAC Human Rotavirus Vaccine Sales by Region (2020-2025) & (K Units)
Table 43. APAC Human Rotavirus Vaccine Sales Market Share by Region (2020-2025)
Table 44. APAC Human Rotavirus Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Human Rotavirus Vaccine Sales by Type (2020-2025) & (K Units)
Table 46. APAC Human Rotavirus Vaccine Sales by Application (2020-2025) & (K Units)
Table 47. Europe Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 48. Europe Human Rotavirus Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Human Rotavirus Vaccine Sales by Type (2020-2025) & (K Units)
Table 50. Europe Human Rotavirus Vaccine Sales by Application (2020-2025) & (K Units)
Table 51. Middle East & Africa Human Rotavirus Vaccine Sales by Country (2020-2025) & (K Units)
Table 52. Middle East & Africa Human Rotavirus Vaccine Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Human Rotavirus Vaccine Sales by Type (2020-2025) & (K Units)
Table 54. Middle East & Africa Human Rotavirus Vaccine Sales by Application (2020-2025) & (K Units)
Table 55. Key Market Drivers & Growth Opportunities of Human Rotavirus Vaccine
Table 56. Key Market Challenges & Risks of Human Rotavirus Vaccine
Table 57. Key Industry Trends of Human Rotavirus Vaccine
Table 58. Human Rotavirus Vaccine Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Human Rotavirus Vaccine Distributors List
Table 61. Human Rotavirus Vaccine Customer List
Table 62. Global Human Rotavirus Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 63. Global Human Rotavirus Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Americas Human Rotavirus Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Americas Human Rotavirus Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. APAC Human Rotavirus Vaccine Sales Forecast by Region (2026-2031) & (K Units)
Table 67. APAC Human Rotavirus Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 68. Europe Human Rotavirus Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Europe Human Rotavirus Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Human Rotavirus Vaccine Sales Forecast by Country (2026-2031) & (K Units)
Table 71. Middle East & Africa Human Rotavirus Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 72. Global Human Rotavirus Vaccine Sales Forecast by Type (2026-2031) & (K Units)
Table 73. Global Human Rotavirus Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 74. Global Human Rotavirus Vaccine Sales Forecast by Application (2026-2031) & (K Units)
Table 75. Global Human Rotavirus Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 76. Bharat Biotech Basic Information, Human Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 77. Bharat Biotech Human Rotavirus Vaccine Product Portfolios and Specifications
Table 78. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Bharat Biotech Main Business
Table 80. Bharat Biotech Latest Developments
Table 81. Merck Basic Information, Human Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Human Rotavirus Vaccine Product Portfolios and Specifications
Table 83. Merck Human Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. GlaxoSmithKline Basic Information, Human Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. GlaxoSmithKline Human Rotavirus Vaccine Product Portfolios and Specifications
Table 88. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Human Rotavirus Vaccine
Figure 2. Human Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Rotavirus Vaccine Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Human Rotavirus Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Rotavirus Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Rotavirus Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Human Rotavirus Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotarix
Figure 12. Product Picture of RotaTeq
Figure 13. Product Picture of Rotavac
Figure 14. Product Picture of Rotavin-M1
Figure 15. Product Picture of Lanzhou lamb
Figure 16. Product Picture of Others
Figure 17. Global Human Rotavirus Vaccine Sales Market Share by Type in 2025
Figure 18. Global Human Rotavirus Vaccine Revenue Market Share by Type (2020-2025)
Figure 19. Human Rotavirus Vaccine Consumed in Hospitals & Clinics
Figure 20. Global Human Rotavirus Vaccine Market: Hospitals & Clinics (2020-2025) & (K Units)
Figure 21. Human Rotavirus Vaccine Consumed in Academic And Research
Figure 22. Global Human Rotavirus Vaccine Market: Academic And Research (2020-2025) & (K Units)
Figure 23. Human Rotavirus Vaccine Consumed in Others
Figure 24. Global Human Rotavirus Vaccine Market: Others (2020-2025) & (K Units)
Figure 25. Global Human Rotavirus Vaccine Sale Market Share by Application (2024)
Figure 26. Global Human Rotavirus Vaccine Revenue Market Share by Application in 2025
Figure 27. Human Rotavirus Vaccine Sales by Company in 2025 (K Units)
Figure 28. Global Human Rotavirus Vaccine Sales Market Share by Company in 2025
Figure 29. Human Rotavirus Vaccine Revenue by Company in 2025 ($ millions)
Figure 30. Global Human Rotavirus Vaccine Revenue Market Share by Company in 2025
Figure 31. Global Human Rotavirus Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Human Rotavirus Vaccine Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Human Rotavirus Vaccine Sales 2020-2025 (K Units)
Figure 34. Americas Human Rotavirus Vaccine Revenue 2020-2025 ($ millions)
Figure 35. APAC Human Rotavirus Vaccine Sales 2020-2025 (K Units)
Figure 36. APAC Human Rotavirus Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Europe Human Rotavirus Vaccine Sales 2020-2025 (K Units)
Figure 38. Europe Human Rotavirus Vaccine Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Human Rotavirus Vaccine Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Human Rotavirus Vaccine Revenue 2020-2025 ($ millions)
Figure 41. Americas Human Rotavirus Vaccine Sales Market Share by Country in 2025
Figure 42. Americas Human Rotavirus Vaccine Revenue Market Share by Country (2020-2025)
Figure 43. Americas Human Rotavirus Vaccine Sales Market Share by Type (2020-2025)
Figure 44. Americas Human Rotavirus Vaccine Sales Market Share by Application (2020-2025)
Figure 45. United States Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Human Rotavirus Vaccine Sales Market Share by Region in 2025
Figure 50. APAC Human Rotavirus Vaccine Revenue Market Share by Region (2020-2025)
Figure 51. APAC Human Rotavirus Vaccine Sales Market Share by Type (2020-2025)
Figure 52. APAC Human Rotavirus Vaccine Sales Market Share by Application (2020-2025)
Figure 53. China Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. India Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Human Rotavirus Vaccine Sales Market Share by Country in 2025
Figure 61. Europe Human Rotavirus Vaccine Revenue Market Share by Country (2020-2025)
Figure 62. Europe Human Rotavirus Vaccine Sales Market Share by Type (2020-2025)
Figure 63. Europe Human Rotavirus Vaccine Sales Market Share by Application (2020-2025)
Figure 64. Germany Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. France Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Human Rotavirus Vaccine Sales Market Share by Application (2020-2025)
Figure 72. Egypt Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Human Rotavirus Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Human Rotavirus Vaccine in 2025
Figure 78. Manufacturing Process Analysis of Human Rotavirus Vaccine
Figure 79. Industry Chain Structure of Human Rotavirus Vaccine
Figure 80. Channels of Distribution
Figure 81. Global Human Rotavirus Vaccine Sales Market Forecast by Region (2026-2031)
Figure 82. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Human Rotavirus Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Human Rotavirus Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Human Rotavirus Vaccine Revenue Market Share Forecast by Application (2026-2031)